Sunshine Biopharma (SBFM) Change in Cash (2010 - 2026)
Sunshine Biopharma's (SBFM) quarterly Change in Cash came in at -$2.2 million in Q1 2026, down 40.27% YoY from -$3.6 million in Q1 2025, and down 131.13% on a QoQ basis from -$941715.0 in Q4 2025.
Sunshine Biopharma (SBFM) Change in Cash (2010 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 17 years of Change in Cash data on file, last reported at -$2.2 million in Q1 2026.
- Quarterly Change in Cash fell 40.27% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.0 million (up 76.39% YoY) and the FY2025 annual result came in at -$1.4 million, up 74.49% from the prior year.
- Change in Cash declined to -$2.2 million in Q1 2026, from -$941715.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $28.5 million in Q2 2022 to a low of -$19.0 million in Q4 2022.
- A 5-year average of $260798.6 and a median of -$941715.0 in 2025 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash soared 41959.55% — and 2024, when it plunged 25270.25%.
- Tracing SBFM's Change in Cash over 5 years: stood at -$19.0 million in 2022, then surged by 84.23% to -$3.0 million in 2023, then jumped by 36.95% to -$1.9 million in 2024, then soared by 50.04% to -$941715.0 in 2025, then slumped by 131.13% to -$2.2 million in 2026.
- The last three Change in Cash figures came in at -$2.2 million (Q1 2026), -$941715.0 (Q4 2025), and -$770560.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | 6.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.88 Mn |
| Mar 31, 2026 | -2.18 Mn |
| Dec 31, 2025 | -941,715.00 |
| Sep 30, 2025 | -770,560.00 |
| Jun 30, 2025 | 1.85 Mn |
| Mar 31, 2025 | -1.55 Mn |
| Dec 31, 2024 | -1.88 Mn |
| Sep 30, 2024 | -73,372.00 |
| Jun 30, 2024 | -5.15 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | -2.99 Mn |
| Sep 30, 2023 | -501,996.00 |
| Jun 30, 2023 | 20,455.00 |
| Mar 31, 2023 | -2.53 Mn |
| Dec 31, 2022 | -18.96 Mn |
| Sep 30, 2022 | -1.12 Mn |
| Jun 30, 2022 | 28.55 Mn |
| Mar 31, 2022 | 11.13 Mn |
| Dec 31, 2021 | -335,777.00 |
| Sep 30, 2021 | 674,883.00 |